Harbin Pharmaceutical Group Co Ltd (600664) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.030x

Based on the latest financial reports, Harbin Pharmaceutical Group Co Ltd (600664) has a cash flow conversion efficiency ratio of -0.030x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-192.19 Million ≈ $-28.12 Million USD) by net assets (CN¥6.41 Billion ≈ $937.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600664 equity to assets ratio to measure how much of total assets are equity-financed.

Harbin Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Harbin Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 600664 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Harbin Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Harbin Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Barloworld Ltd JSE:BAW	0.282x
Guangdong Golden Dragon Development Inc SHE:000712	0.203x
Lithium Argentina AG NYSE:LAR	-0.008x
CompuGroup Medical SE & Co. KGaA XETRA:COP	0.144x
Chengdu Fusen Noble-House Industrial Co Ltd SHE:002818	0.060x
Compass Minerals International Inc NYSE:CMP	0.720x
TF Bank AB ST:TFBANK	-0.024x
MRC Global Inc NYSE:MRC	-0.070x

Annual Cash Flow Conversion Efficiency for Harbin Pharmaceutical Group Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Harbin Pharmaceutical Group Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see 600664 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥6.09 Billion ≈ $891.05 Million	CN¥792.50 Million ≈ $115.97 Million	0.130x	-25.68%
2023-12-31	CN¥5.42 Billion ≈ $793.53 Million	CN¥949.67 Million ≈ $138.97 Million	0.175x	+39.38%
2022-12-31	CN¥4.95 Billion ≈ $724.49 Million	CN¥622.09 Million ≈ $91.03 Million	0.126x	+441.93%
2021-12-31	CN¥4.42 Billion ≈ $646.86 Million	CN¥-162.44 Million ≈ $-23.77 Million	-0.037x	+79.87%
2020-12-31	CN¥3.99 Billion ≈ $583.65 Million	CN¥-728.15 Million ≈ $-106.55 Million	-0.183x	-280.76%
2019-12-31	CN¥5.94 Billion ≈ $869.62 Million	CN¥-284.94 Million ≈ $-41.70 Million	-0.048x	-143.47%
2018-12-31	CN¥6.28 Billion ≈ $919.10 Million	CN¥692.72 Million ≈ $101.37 Million	0.110x	+452.97%
2017-12-31	CN¥7.48 Billion ≈ $1.09 Billion	CN¥149.22 Million ≈ $21.84 Million	0.020x	-94.04%
2016-12-31	CN¥8.30 Billion ≈ $1.21 Billion	CN¥2.78 Billion ≈ $406.51 Million	0.335x	+50.91%
2015-12-31	CN¥7.48 Billion ≈ $1.09 Billion	CN¥1.66 Billion ≈ $242.91 Million	0.222x	+71.25%
2014-12-31	CN¥8.77 Billion ≈ $1.28 Billion	CN¥1.14 Billion ≈ $166.25 Million	0.130x	+702.39%
2013-12-31	CN¥8.77 Billion ≈ $1.28 Billion	CN¥141.64 Million ≈ $20.73 Million	0.016x	-74.96%
2012-12-31	CN¥8.65 Billion ≈ $1.27 Billion	CN¥557.83 Million ≈ $81.63 Million	0.064x	+1410.01%
2011-12-31	CN¥6.41 Billion ≈ $938.47 Million	CN¥-31.56 Million ≈ $-4.62 Million	-0.005x	-102.79%
2010-12-31	CN¥6.55 Billion ≈ $957.81 Million	CN¥1.15 Billion ≈ $168.67 Million	0.176x	-43.08%
2009-12-31	CN¥5.98 Billion ≈ $875.69 Million	CN¥1.85 Billion ≈ $270.95 Million	0.309x	+209.57%
2008-12-31	CN¥5.79 Billion ≈ $847.08 Million	CN¥578.59 Million ≈ $84.67 Million	0.100x	-22.30%
2007-12-31	CN¥5.05 Billion ≈ $739.58 Million	CN¥650.16 Million ≈ $95.14 Million	0.129x	-13.48%
2006-12-31	CN¥4.96 Billion ≈ $726.45 Million	CN¥738.08 Million ≈ $108.00 Million	0.149x	-13.82%
2005-12-31	CN¥4.39 Billion ≈ $642.77 Million	CN¥757.76 Million ≈ $110.88 Million	0.173x	+352.24%
2004-12-31	CN¥3.91 Billion ≈ $571.61 Million	CN¥149.01 Million ≈ $21.80 Million	0.038x	-60.58%
2003-12-31	CN¥3.13 Billion ≈ $457.96 Million	CN¥302.83 Million ≈ $44.31 Million	0.097x	-27.37%
2002-12-31	CN¥2.88 Billion ≈ $421.18 Million	CN¥383.44 Million ≈ $56.11 Million	0.133x	-40.95%
2001-12-31	CN¥2.68 Billion ≈ $391.86 Million	CN¥604.13 Million ≈ $88.40 Million	0.226x	-32.31%
2000-12-31	CN¥1.63 Billion ≈ $237.84 Million	CN¥541.70 Million ≈ $79.27 Million	0.333x	+14.09%
1999-12-31	CN¥1.48 Billion ≈ $216.01 Million	CN¥431.22 Million ≈ $63.10 Million	0.292x	+67.75%
1998-12-31	CN¥1.27 Billion ≈ $186.06 Million	CN¥221.41 Million ≈ $32.40 Million	0.174x	--

About Harbin Pharmaceutical Group Co Ltd

SHG:600664 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.17 Billion

CN¥8.01 Billion CNY

Market Cap Rank

#8339 Global

#2006 in China

Share Price

CN¥3.18

Change (1 day)

+1.27%

52-Week Range

CN¥2.93 - CN¥4.44

All Time High

CN¥8.34